查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1734911

2032 年藥用管瓶和安瓿瓶市場預測：按產品、材料、產能、應用、最終用戶和地區進行的全球分析

Pharmaceutical Glass Vials and Ampoules Market Forecasts to 2032 - Global Analysis By Product (Vials, Ampoules, Pre-filled Syringes and Dropper Bottles), Material, Capacity, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球藥用管瓶和安瓿瓶市場預計在 2025 年達到 158 億美元，預計到 2032 年將達到 286 億美元，預測期內的複合年成長率為 8.9%。

藥用玻璃西林管瓶和安瓿瓶是製藥業用於儲存和運輸液體和粉末藥物的專用容器。西林管瓶是圓柱形的小瓶子，底部平坦，配有橡膠塞或螺旋蓋，常用於注射和疫苗。安瓿瓶是密封的玻璃容器，用於盛裝單劑量無菌注射劑，必須打破才能取出內容物。兩者均採用優質硼矽酸或鈉鈣玻璃製成，以確保化學穩定性、耐用性和抗熱衝擊性，從而保護藥效並防止污染。

據印度藥品製造商協會 (IDMA) 稱，古吉拉突邦的藥品產量約佔印度全國的 33%。

對生物製藥和注射療法的需求不斷增加

生物製藥和注射療法的需求日益成長，推動了藥用管瓶和安瓿瓶市場的發展。隨著先進生技藥品和個人化醫療的日益普及，對無菌、安全且化學惰性的包裝的需求也日益成長。管瓶和安瓿瓶具有優異的阻隔性，並且與敏感製劑相容，使其成為注射劑的理想選擇。生物製藥的發展以及腸外給藥的激增，正在推動整個製藥行業包裝解決方案的持續成長和創新。

製造和營運成本高

高昂的製造和營運成本是藥用管瓶和安瓿瓶市場面臨的重大挑戰。這些成本源自於昂貴的原料、先進的製造流程和嚴格的品管標準。因此，製造商面臨著在確保產品安全性和可靠性的同時保持價格競爭力的壓力。這些因素可能會影響盈利、限制創新，並導致產品價格上漲，最終影響最終用戶的可及性，並降低市場成長潛力。

技術進步

技術進步正積極改變藥用管瓶和安瓿瓶市場，提升產品品質、安全性和效率。精密成型、改良的滅菌技術和智慧包裝等創新技術能夠保護藥品的完整性並延長保存期限。自動化和數位化追蹤簡化了生產和供應鏈管理，降低了污染風險和人為錯誤。這些發展有助於滿足法規合規性，並滿足製藥業對高純度、無污染包裝日益成長的需求，最終推動市場成長。

脆弱性和處理挑戰

由於易碎性和搬運問題，藥用管瓶和安瓿瓶市場面臨巨大挑戰。這些容器在使用、儲存和運輸過程中容易破損，導致成本增加、安全問題和產品損失。由於需要專業包裝和搬運解決方案，物流複雜性也影響了供應鏈效率。因此，生產商正在投資購買更堅固的材料，但易碎性仍然是一個問題。

COVID-19的影響

新冠疫情對藥用管瓶和安瓿瓶市場產生了重大影響。疫苗生產和分銷的激增凸顯了對可靠包裝解決方案的需求。這導致對管瓶的需求增加，並促使製造商擴大生產規模。然而，原料短缺、供應鏈中斷以及嚴格的監管要求等挑戰也帶來了阻礙。儘管面臨這些挑戰，但市場仍在不斷湧現創新和投資，推動著該產業的成長。

預計預測期內火石玻璃部分將成為最大的部分。

火石玻璃透明度高、經濟高效且與各種製劑相容，預計在預測期內將佔據最大的市場佔有率。它能夠清晰地顯示內容物，確保更好的品管和患者安全，尤其適用於非光敏性注射藥物。此外，它易於成型和加工，可實現擴充性生產，對於尋求高效可靠包裝解決方案的製藥商來說，它是一種極具吸引力的選擇。

生技藥品領域預計將在預測期內實現最高複合年成長率

預計生物製藥領域將在預測期內實現最高成長率。這是因為生物製藥高度敏感且需要複雜的儲存條件。這些治療方法需要無菌、無反應的容器來確保產品完整性，因此玻璃管瓶和安瓿瓶成為首選。生技藥品投資的不斷成長、單株抗體和基因療法核准的不斷增加，正在推動對優質藥用玻璃包裝的需求，從而刺激管瓶設計的技術創新，並擴大整個行業的生產能力。

佔比最高的地區：

預計亞太地區將在預測期內佔據最大的市場佔有率，因為注射劑、疫苗和生物製藥的需求不斷成長，推動了人們採用能夠確保安全性和延長保存期限的優質包裝解決方案。政府在醫療保健方面的支出不斷增加，以及印度和中國等國製藥製造業基地的不斷擴張，進一步推動了這一成長。此外，玻璃技術的進步正在推動永續性和精準性，從而增強該地區的整體醫療保健生態系統。

複合年成長率最高的地區：

在預測期內，由於對安全可靠的醫藥包裝解決方案的需求不斷成長，預計北美將呈現最高的複合年成長率。該地區強大的醫藥製造基礎加上嚴格的監管標準，確保了高品質的生產。技術進步以及生技藥品和注射的興起進一步推動了市場擴張。這種成長透過提高藥物的穩定性和安全性，對公眾健康產生了積極影響，同時支持了北美各地醫藥包裝行業的技術創新和永續性發展。

免費客製化服務

訂閱此報告的客戶可享有以下免費自訂選項之一：

  • 公司簡介
    • 全面分析其他市場參與者（最多 3 家公司）
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球藥用管瓶和安瓿瓶市場（按產品）

  • 管瓶
  • 安瓿
  • 預填充式注射器
  • 滴管瓶

6. 全球藥用管瓶和安瓿瓶市場（依材質）

  • 硼硼矽酸玻璃
  • 火石玻璃
  • 聚丙烯

7. 全球藥用管瓶和安瓿瓶市場（按數量）

  • 小於2毫升
  • 2ml～5ml
  • 5ml～10ml
  • 10毫升或更多

8. 全球藥用管瓶和安瓿瓶市場（按應用）

  • 疫苗
  • 注射
  • 生物製藥
  • 化療藥物
  • 腫瘤藥物
  • 其他用途

第9章全球藥用管瓶和安瓿瓶市場（按最終用戶）

  • 製藥公司
  • 生物製藥公司
  • 契約製造組織（CMO）
  • 研究和學術機構
  • 其他最終用戶

第 10 章全球藥用管瓶和安瓿瓶市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Gerresheimer AG
  • Schott AG
  • SGD Pharma
  • Stevanato Group
  • Nipro Corporation
  • Corning Incorporated
  • Shandong Pharmaceutical Glass Co., Ltd.
  • Piramal Glass
  • Borosil Limited
  • Ardagh Group
  • West Pharmaceutical Services, Inc.
  • Bormioli Pharma
  • Owens-Illinois, Inc.
  • AAPL Solutions Pvt. Ltd.
  • Hindusthan National Glass & Industries Ltd
  • Accu-Glass LLC
  • Stoelzle Glass Group
  • DWK Life Sciences GmbH
Product Code: SMRC29548

According to Stratistics MRC, the Global Pharmaceutical Glass Vials and Ampoules Market is accounted for $15.8 billion in 2025 and is expected to reach $28.6 billion by 2032 growing at a CAGR of 8.9% during the forecast period. Pharmaceutical glass vials and ampoules are specialized containers used to store and transport liquid and powdered medications in the pharmaceutical industry. Vials are small, cylindrical bottles with a flat bottom and a rubber stopper or screw cap, commonly used for injectable drugs and vaccines. Ampoules are sealed glass containers that hold a single dose of sterile injectable medicine and must be broken open to access the contents. Both are made from high-quality borosilicate or soda-lime glass to ensure chemical stability, durability, and resistance to thermal shock, protecting drug efficacy and preventing contamination.

According to the Indian Drug Manufacturers' Association (IDMA), Gujarat contributes to about 33% of the country's pharmaceutical production.

Market Dynamics:

Driver:

Rising Demand for Biopharmaceuticals and Injectable Therapies

The rising demand for biopharmaceuticals and injectable therapies is significantly boosting the pharmaceutical glass vials and ampoules market. As advanced biologics and personalized medicines gain traction, the need for sterile, secure, and chemically inert packaging grows. Glass vials and ampoules offer excellent barrier properties and compatibility with sensitive formulations, making them ideal for injectable drugs. This surge in biologic drug development and parenteral administration is driving consistent growth and innovation in packaging solutions across the pharmaceutical industry.

Restraint:

High Production and Operational Costs

High production and operational costs in the pharmaceutical glass vials and ampoules market pose significant challenges. These costs arise from expensive raw materials, advanced manufacturing processes, and stringent quality control standards. As a result, manufacturers face pressure to maintain competitive pricing while ensuring product safety and reliability. These factors hinder profitability, limit innovation, and may lead to higher product prices, ultimately affecting accessibility for end-users and reducing market growth potential.

Opportunity:

Technological Advancements

Technological advancements are positively transforming the pharmaceutical glass vials and ampoules market by enhancing product quality, safety, and efficiency. Innovations such as precision forming, improved sterilization techniques, and smart packaging enable better protection of drug integrity and longer shelf life. Automation and digital tracking streamline production and supply chain management, reducing contamination risks and human error. These developments support regulatory compliance and meet growing demand for high-purity, contamination-free packaging in the pharmaceutical industry, ultimately driving market growth.

Threat:

Fragility and Handling Challenges

The pharmaceutical glass vials and ampoules market is facing considerable hurdles due to fragility and handling issues. These containers are prone to breaking during usage, storage, and transit, which can lead to higher expenses, safety hazards, and product loss. Supply chain efficiency is impacted by the complexity of logistics brought on by the requirement for specialized packaging and handling solutions. Consequently, producers are spending money on stronger materials, yet fragility is still a problem.

Covid-19 Impact

The COVID-19 pandemic significantly impacted the pharmaceutical glass vials and ampoules market. The surge in vaccine production and distribution highlighted the critical need for reliable packaging solutions. This led to increased demand for glass vials, prompting manufacturers to scale up production. However, challenges such as raw material shortages, supply chain disruptions, and stringent regulatory requirements posed obstacles. Despite these challenges, the market has seen innovation and investment, driving growth in the sector.

The flint glass segment is expected to be the largest during the forecast period

The flint glass segment is expected to account for the largest market share during the forecast period, due to its excellent clarity, cost-effectiveness, and compatibility with a wide range of drug formulations. Its ability to provide clear visibility of contents ensures better quality control and patient safety, especially for non-sensitive injectable drugs. Moreover, its ease of molding and processing supports scalable production, making it an attractive choice for pharmaceutical manufacturers seeking efficient and reliable packaging solutions.

The biologics segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the biologics segment is predicted to witness the highest growth rate, due to the high sensitivity and complex storage needs of biologic drugs. These therapies require sterile, non-reactive containers to ensure product integrity, making glass vials and ampoules the preferred choice. Rising investments in biologics and increasing approvals of monoclonal antibodies and gene therapies are boosting demand for premium pharmaceutical glass packaging, fostering innovation in vial design and expanding production capacity across the industry.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share because of Rising demand for injectable drugs, vaccines, and biopharmaceuticals is driving adoption of high-quality packaging solutions, ensuring safety and extended shelf life. Governments' increased healthcare spending and the expansion of pharmaceutical production hubs in countries like India and China further fuel this growth. Additionally, advancements in glass technology promote sustainability and precision, enhancing the overall healthcare ecosystem in the region.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to rising demand for safe, reliable drug packaging solutions. The region's strong pharmaceutical manufacturing base, coupled with stringent regulatory standards, ensures high-quality production. Technological advancements and the rise in biologics and injectable drugs are further propelling market expansion. This growth positively impacts public health by enhancing drug stability and safety, while supporting innovation and sustainability efforts within the pharmaceutical packaging industry across North America.

Key players in the market

Some of the key players profiled in the Pharmaceutical Glass Vials and Ampoules Market include Gerresheimer AG, Schott AG, SGD Pharma, Stevanato Group, Nipro Corporation, Corning Incorporated, Shandong Pharmaceutical Glass Co., Ltd., Piramal Glass, Borosil Limited, Ardagh Group, West Pharmaceutical Services, Inc., Bormioli Pharma, Owens-Illinois, Inc., AAPL Solutions Pvt. Ltd., Hindusthan National Glass & Industries Ltd, Accu-Glass LLC, Stoelzle Glass Group and DWK Life Sciences GmbH.

Key Developments:

In May 2025, SCHOTT Pharma and Serum Institute of India (SII) have welcomed TPG Growth as a new strategic partner in their joint venture, SCHOTT Poonawalla. This collaboration marks a significant development in the pharmaceutical packaging sector in India.

In November 2023, SCHOTT and Accelink Technologies, a prominent provider of optical communication solutions, announced a long-term strategic partnership at the China International Import Expo (CIIE) in Shanghai. This collaboration aims to enhance the fiber optic communication supply chain and foster technological advancements in the field.

Products Covered:

  • Vials
  • Ampoules
  • Pre-filled Syringes
  • Dropper Bottles

Materials Covered:

  • Borosilicate Glass
  • Flint Glass
  • Polypropylene

Capacities Covered:

  • Less than 2ml
  • 2ml to 5ml
  • 5ml to 10ml
  • More than 10ml

Applications Covered:

  • Vaccines
  • Injectables
  • Biologics
  • Chemotherapy Drugs
  • Oncology Drugs
  • Other Applications

End Users Covered:

  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations (CMOs)
  • Research and Academic Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pharmaceutical Glass Vials and Ampoules Market, By Product

  • 5.1 Introduction
  • 5.2 Vials
  • 5.3 Ampoules
  • 5.4 Pre-filled Syringes
  • 5.5 Dropper Bottles

6 Global Pharmaceutical Glass Vials and Ampoules Market, By Material

  • 6.1 Introduction
  • 6.2 Borosilicate Glass
  • 6.3 Flint Glass
  • 6.4 Polypropylene

7 Global Pharmaceutical Glass Vials and Ampoules Market, By Capacity

  • 7.1 Introduction
  • 7.2 Less than 2ml
  • 7.3 2ml to 5ml
  • 7.4 5ml to 10ml
  • 7.5 More than 10ml

8 Global Pharmaceutical Glass Vials and Ampoules Market, By Application

  • 8.1 Introduction
  • 8.2 Vaccines
  • 8.3 Injectables
  • 8.4 Biologics
  • 8.5 Chemotherapy Drugs
  • 8.6 Oncology Drugs
  • 8.7 Other Applications

9 Global Pharmaceutical Glass Vials and Ampoules Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceutical Companies
  • 9.3 Biopharmaceutical Companies
  • 9.4 Contract Manufacturing Organizations (CMOs)
  • 9.5 Research and Academic Institutes
  • 9.6 Other End Users

10 Global Pharmaceutical Glass Vials and Ampoules Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Gerresheimer AG
  • 12.2 Schott AG
  • 12.3 SGD Pharma
  • 12.4 Stevanato Group
  • 12.5 Nipro Corporation
  • 12.6 Corning Incorporated
  • 12.7 Shandong Pharmaceutical Glass Co., Ltd.
  • 12.8 Piramal Glass
  • 12.9 Borosil Limited
  • 12.10 Ardagh Group
  • 12.11 West Pharmaceutical Services, Inc.
  • 12.12 Bormioli Pharma
  • 12.13 Owens-Illinois, Inc.
  • 12.14 AAPL Solutions Pvt. Ltd.
  • 12.15 Hindusthan National Glass & Industries Ltd
  • 12.16 Accu-Glass LLC
  • 12.17 Stoelzle Glass Group
  • 12.18 DWK Life Sciences GmbH

List of Tables

  • Table 1 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Vials (2024-2032) ($MN)
  • Table 4 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Ampoules (2024-2032) ($MN)
  • Table 5 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Pre-filled Syringes (2024-2032) ($MN)
  • Table 6 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Dropper Bottles (2024-2032) ($MN)
  • Table 7 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Material (2024-2032) ($MN)
  • Table 8 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Borosilicate Glass (2024-2032) ($MN)
  • Table 9 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Flint Glass (2024-2032) ($MN)
  • Table 10 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Polypropylene (2024-2032) ($MN)
  • Table 11 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Capacity (2024-2032) ($MN)
  • Table 12 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Less than 2ml (2024-2032) ($MN)
  • Table 13 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By 2ml to 5ml (2024-2032) ($MN)
  • Table 14 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By 5ml to 10ml (2024-2032) ($MN)
  • Table 15 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By More than 10ml (2024-2032) ($MN)
  • Table 16 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Application (2024-2032) ($MN)
  • Table 17 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Vaccines (2024-2032) ($MN)
  • Table 18 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Injectables (2024-2032) ($MN)
  • Table 19 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Biologics (2024-2032) ($MN)
  • Table 20 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Chemotherapy Drugs (2024-2032) ($MN)
  • Table 21 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Oncology Drugs (2024-2032) ($MN)
  • Table 22 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 23 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By End User (2024-2032) ($MN)
  • Table 24 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Pharmaceutical Companies (2024-2032) ($MN)
  • Table 25 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Biopharmaceutical Companies (2024-2032) ($MN)
  • Table 26 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Contract Manufacturing Organizations (CMOs) (2024-2032) ($MN)
  • Table 27 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Research and Academic Institutes (2024-2032) ($MN)
  • Table 28 Global Pharmaceutical Glass Vials and Ampoules Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.